Literature DB >> 8347147

Anti-HIV-1 activity and cellular pharmacology of various analogs of gossypol.

T S Lin1, R F Schinazi, J Zhu, E Birks, R Carbone, Y Si, K Wu, L Huang, W H Prusoff.   

Abstract

We previously reported that the racemic mixture and both enantiomers of gossypol inhibit the replication of human immunodeficiency virus-type 1 (HIV-1) (Lin et al., Antimicrob Agents Chemother 33: 2149-2151, 1989). The present study evaluates the activities of a variety of analogs of gossypol as well as a few non-gossypol analogs. Compounds 2, 3, 10, and 13 were slightly more inhibitory than (-)-gossypol to the replication of HIV-1 in cell culture. Compounds 4 and 8 were cytotoxic to human peripheral blood monocyte (PBM) cells, and compounds 2 and 3 were cytotoxic to Vero cells but not PBM cells. The effects of the two enantiomers of gossypol on the cell volume and migration of H9 cells through the cell cycle were evaluated during 72 hr of incubation. The (-)-enantiomer of gossypol was more toxic to H9 cells than the (+)-enantiomer of gossypol as evidenced by cell destruction. Prior to cell destruction, there appeared to be no significant effect on cell cycle distribution with either enantiomer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8347147     DOI: 10.1016/0006-2952(93)90411-o

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

Review 1.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

2.  Effect of racemic and (+)- and (-)-gossypol on the survival and development of Helicoverpa zea larvae.

Authors:  Robert D Stipanovic; Juan D Lopez; Michael K Dowd; Lorraine S Puckhaber; Sara E Duke
Journal:  J Chem Ecol       Date:  2006-05-19       Impact factor: 2.626

3.  Developing gossypol derivatives with enhanced antitumor activity.

Authors:  X S Liang; A J Rogers; C L Webber; T J Ormsby; M E Tiritan; S A Matlin; C C Benz
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

4.  A gossypol derivative effectively protects against Zika and dengue virus infection without toxicity.

Authors:  Yaning Gao; Wanbo Tai; Xinyi Wang; Shibo Jiang; Asim K Debnath; Lanying Du; Shizhong Chen
Journal:  BMC Biol       Date:  2022-06-15       Impact factor: 7.364

5.  First discovery of acetone extract from cottonseed oil sludge as a novel antiviral agent against plant viruses.

Authors:  Lei Zhao; Chaohong Feng; Caiting Hou; Lingyun Hu; Qiaochun Wang; Yunfeng Wu
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

6.  Gossypol from Cottonseeds Ameliorates Glucose Uptake by Mimicking Insulin Signaling and Improves Glucose Homeostasis in Mice with Streptozotocin-Induced Diabetes.

Authors:  Md Badrul Alam; Hongyan An; Jeong-Sic Ra; Ji-Young Lim; Seung-Hyun Lee; Chi-Yeol Yoo; Sang-Han Lee
Journal:  Oxid Med Cell Longev       Date:  2018-10-28       Impact factor: 6.543

7.  Effects of gossypol on apoptosis‑related gene expression in racially distinct triple‑negative breast cancer cells.

Authors:  Samia S Messeha; Najla O Zarmouh; Patricia Mendonca; Hayfaa Alwagdani; Carolyn Cotton; Karam F A Soliman
Journal:  Oncol Rep       Date:  2019-05-31       Impact factor: 3.906

8.  Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?

Authors:  Qing Yu; Yi Sun
Journal:  Drug Des Devel Ther       Date:  2021-01-06       Impact factor: 4.162

Review 9.  Antiviral Potential of Selected Medicinal Herbs and Their Isolated Natural Products.

Authors:  W P R T Perera; Janitha A Liyanage; K G C Dissanayake; Hiruni Gunathilaka; W M T D N Weerakoon; D N Wanigasekara; W S K Fernando; R M H Rajapaksha; R P Liyanage; Bingun T Perera
Journal:  Biomed Res Int       Date:  2021-12-08       Impact factor: 3.411

10.  The interaction of PVP complexes of gossypol and its derivatives with an artificial membrane lipid matrix.

Authors:  Maksim Ionov; Ilnora Tukfatullina; Bakhtiyar Salakhutdinov; Nina Baram; Maria Bryszewska; Takhir Aripov
Journal:  Cell Mol Biol Lett       Date:  2009-11-20       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.